Calcium Channel Blockers--Benefits Upon Vascular Biology in Hypertensive Patients

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Medical Research

Background:

• Calcium channel blockers (CCBs) are vital in managing hypertension and reducing cardiovascular events.
• Asymptomatic hypertensive patients without existing cardiovascular disease represent a key population for preventative strategies.

Purpose of the Study:

• To evaluate the efficacy of lercanidipine in improving cardiovascular parameters in Romanian hypertensive patients.
• To assess the impact of lercanidipine on arterial elasticity, stiffness, and lipid profiles.
• To explore the molecular mechanisms underlying lercanidipine's potency using in silico methods.

Main Methods:

• Clinical assessment of 58 asymptomatic hypertensive patients.
• Measurement of arterial elasticity and stiffness (e.g., pulse wave velocity).
• Quantification of anthropometric and metabolic (lipid) parameters.
• In silico molecular simulation techniques to analyze CCB potency.

Main Results:

• Lercanidipine 10 mg daily for three weeks significantly improved central aortic systolic blood pressure and aortic pulse wave velocity.
• Improvement in lipid profile was observed, correlating with enhanced elastic vascular properties.
• Molecular descriptors (surface areas, polarizability, partition coefficient) elucidated lercanidipine's calcium channel blocking effect.

Conclusions:

• Lercanidipine demonstrates significant efficacy in improving key hemodynamic and vascular parameters in hypertensive individuals.
• Optimizing lipid profiles is essential for enhancing vascular elasticity and mitigating cardiovascular risk.
• In silico analysis provides valuable insights into the molecular basis of lercanidipine's therapeutic action.